Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 2Recruiting 2Active not recruiting 2Withdrawn 1Suspended 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Prostatic Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 6fludarabine phosphate 5Cytarabine 4Peripheral Blood Stem Cell Transplantation 3Methotrexate 3Doxorubicin 3venetoclax 2navitoclax 2merphos 2fludarabine 2Whole-Body Irradiation 2Vincristine 2Pentetic Acid 2Mycophenolic Acid 2Filgrastim 2Etoposide 2Daunorubicin 2Biopsy 2Asparaginase 2sargramostim 1romidepsin 1prednylidene 1pegaspargase 1nelarabine 1lentiviral minigene vaccine of COVID-19 coronavirus 1hydrocortisone hemisuccinate 1ethanolamine oleate 1duvelisib 1dexamethasone acetate 1dexamethasone 21-phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × prednylidene × Clear all
NCT02538926 2018-11-14

Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride With Asparaginase in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

University of Washington

Phase 2 Withdrawn
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡